- Home
- MNKD vs SPNS Comparison
MNKD vs SPNS Comparison
Compare MNKD & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- SPNS
- Stock Information
- Founded
- MNKD 1991
- SPNS 1982
- Country
- MNKD United States
- SPNS Israel
- Employees
- MNKD N/A
- SPNS N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- MNKD Health Care
- SPNS Technology
- Exchange
- MNKD Nasdaq
- SPNS Nasdaq
- Market Cap
- MNKD 1.4B
- SPNS 1.6B
- IPO Year
- MNKD 2004
- SPNS 1992
- Fundamental
- Price
- MNKD $3.77
- SPNS $28.39
- Analyst Decision
- MNKD Buy
- SPNS Buy
- Analyst Count
- MNKD 4
- SPNS 4
- Target Price
- MNKD $9.75
- SPNS $34.25
- AVG Volume (30 Days)
- MNKD 2.6M
- SPNS 137.9K
- Earning Date
- MNKD 08-06-2025
- SPNS 07-31-2025
- Dividend Yield
- MNKD N/A
- SPNS 3.35%
- EPS Growth
- MNKD 228.27
- SPNS 11.11
- EPS
- MNKD 0.10
- SPNS 1.30
- Revenue
- MNKD $297,595,000.00
- SPNS $544,235,000.00
- Revenue This Year
- MNKD $13.72
- SPNS $8.30
- Revenue Next Year
- MNKD $15.21
- SPNS $7.42
- P/E Ratio
- MNKD $36.35
- SPNS $21.84
- Revenue Growth
- MNKD 32.50
- SPNS 3.84
- 52 Week Low
- MNKD $3.63
- SPNS $23.69
- 52 Week High
- MNKD $7.63
- SPNS $41.22
- Technical
- Relative Strength Index (RSI)
- MNKD 34.62
- SPNS 48.36
- Support Level
- MNKD $3.63
- SPNS $27.82
- Resistance Level
- MNKD $3.85
- SPNS $28.80
- Average True Range (ATR)
- MNKD 0.15
- SPNS 0.52
- MACD
- MNKD -0.02
- SPNS -0.14
- Stochastic Oscillator
- MNKD 16.47
- SPNS 21.92
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.